Sleep Inducing Drugs: Classification And Their Effects

which drug classification is used to produce sleep

Sleep disorders can be broadly categorized into three groups: those producing insomnia, those with a primary complaint of daytime sleepiness, and those associated with disruptive behaviors during sleep. There is a range of medications used to treat these disorders, including hypnotics, stimulants, antidepressants, antihistamines, and anti-Parkinsonian drugs. Hypnotics, which include benzodiazepines and nonbenzodiazepines, are commonly used to treat insomnia and other sleep disorders. They are often referred to as sedative-hypnotic drugs due to their dose-dependent effects, which can range from anxiolysis to loss of consciousness. Stimulants, such as amphetamine-like compounds and caffeine, are used to control excessive sleepiness. Antidepressants, such as amitriptyline and trimipramine, are used to treat insomnia when patients experience sedating side effects. Antihistamines, such as doxylamine and diphenhydramine, are also used to treat insomnia, either prescribed or purchased over the counter. Anti-Parkinsonian drugs, such as gabapentin enacarbil and pramipexole, are used to treat restless leg syndrome and periodic limb movement disorder.

Characteristics Values
Drug Classification Hypnotics, Sedatives, Anticonvulsants, Antidepressants, Antihistamines, Benzodiazepines, Nonbenzodiazepines, Quinazolinones, Barbiturates, Antinarcoleptics, Stimulants
Use Treatment of insomnia and other sleep disorders
Prescription Sleeping pills, gabapentin enacarbil, pregabalin, alprazolam, clonazepam, diazepam, etc.
Over-the-counter Doxylamine, diphenhydramine, melatonin supplements
Side Effects Dependence, accidents, daytime fatigue, cognitive impairment, overdose
Treatment Duration Short-term, used for the shortest period necessary
Combination Works best with good sleep practices and behavioural treatments

shunsleep

Benzodiazepines

While benzodiazepines have therapeutic benefits, they are associated with adverse effects, especially in older patients, including falls, cognitive impairment, and an increased risk of dementia. They can also lead to addiction, altered judgment, medical morbidity, and deaths from overdose. Due to these risks, physicians are advised to be cautious when prescribing benzodiazepines, and patients should take the lowest effective dose for the shortest therapeutic time.

There are various types of benzodiazepines, including Alprazolam (Xanax), Quazepam (Doral), Remimazolam (Byfavo), Temazepam (Restoril), and Triazolam (Halcion). Some benzodiazepines act on the brain and body for longer than others, and they can have different levels of potency. It is important to note that some benzodiazepines, like diazepam, produce additional benzodiazepine chemicals when metabolized by the body, prolonging their overall effect.

shunsleep

Nonbenzodiazepines

The first three nonbenzodiazepine drugs to enter the market were zopiclone, zolpidem, and zaleplon. These drugs are sedatives used exclusively for the treatment of mild insomnia and are considered safer than older barbiturates. They may have a lower tendency to induce physical dependence and addiction compared to benzodiazepines, but these issues can still become a problem. Zaleplon, in particular, may have fewer side effects compared to benzodiazepines, and tolerance and rebound effects may not occur with this drug. However, most research has demonstrated negative effects of Z-drugs on cognitive performance, with greater sleep-inducing efficacy resulting in greater impairment.

shunsleep

Anticonvulsants

While the effects of AEDs on sleep are not yet fully understood, studies have shown that these drugs can significantly impact sleep architecture. For example, controlled-release Carbamazepine (CBZ-CR) has been found to increase the number of stage shifts, reduce REM sleep, and increase REM sleep fragmentation. Similarly, Phenytoin may increase light sleep while decreasing sleep efficiency and REM sleep. On the other hand, Gabapentin has been shown to enhance slow-wave sleep and increase sleep continuity, reducing the number of awakenings. It has also been suggested as a possible treatment for restless leg syndrome, a common sleep disorder.

The effects of AEDs on sleep may vary depending on the specific drug and the individual's medical condition. For instance, while Carbamazepine and Phenytoin may disrupt sleep, Lamotrigine has been found to decrease slow-wave sleep in some patients while having no effect in others.

In summary, while anticonvulsants can have varying effects on sleep, they have been shown to enhance sleep stability in some cases. However, more research is needed to fully understand the impact of these drugs on sleep architecture and to optimize their use in treating sleep disorders. Patients with sleep problems taking anticonvulsants may need to adjust their dosing or switch to another drug under medical supervision.

shunsleep

Antidepressants

Hypnotic drugs are the most common drug classification used to induce sleep. They are regularly prescribed for insomnia and other sleep disorders, with over 95% of insomnia patients being prescribed hypnotics in some countries. However, many hypnotic drugs are habit-forming and can cause adverse effects such as dependence and accidents. Therefore, physicians may recommend non-pharmacological interventions such as improving sleep hygiene and avoiding stimulants before prescribing hypnotic medications.

Doxepin (Silenor) is the only FDA-approved antidepressant for the treatment of insomnia. It produces sedating effects at low doses and helps people fall and stay asleep. It is generally taken 30 minutes before bedtime and should be taken at least 3 hours after eating, as food can decrease its sedating effects. Research has shown that doxepin may be effective in improving sleep for up to 3 months.

Other antidepressants with sedating side effects may also be used off-label as sleep aids. Doctors individualize the doses of these medications based on their impact on sleep and the tolerability of side effects. However, the tolerability and safety of antidepressants for insomnia are uncertain due to limited reporting of adverse events. Therefore, high-quality trials of antidepressants for insomnia are needed to establish their effectiveness and safety.

shunsleep

Anti-Parkinsonian drugs

Sleep is an essential physiological process that allows the body and mind to recover and rejuvenate. However, for individuals with Parkinson's disease (PD), sleep disturbances and disorders are prevalent challenges. The complexity of PD and its impact on sleep necessitate careful consideration of treatment options, including anti-Parkinsonian drugs.

When addressing sleep issues in PD, a comprehensive approach is necessary. This involves considering the potential benefits and drawbacks of various anti-Parkinsonian drugs on sleep. For instance, while quetiapine is widely used in PD, its efficacy is questionable, and it carries an increased risk of adverse effects, including mortality. On the other hand, clozapine has shown promise in improving sleep fragmentation, insomnia, and nocturnal disturbances in PD patients, although it can cause excessive daytime sleepiness (EDS) in up to half of treated patients.

Beyond anti-Parkinsonian drugs, other pharmacological options exist to address sleep issues in PD. These include antidepressants, such as trazodone and Remeron, and drugs targeting specific sleep disorders associated with PD, like Clonazepam for REM behaviour sleep disorder. Additionally, melatonin receptor agonists, such as ramelteon and tasimelteon, have been used to treat sleep disorders, and agomelatine, an antidepressant in this class, has also shown positive effects on sleep.

It is important to note that the choice of medication should be tailored to the individual, considering their unique clinical situation. Trial and error may be necessary to find the most suitable option. Furthermore, non-pharmacological approaches, such as deep brain stimulation (DBS), have been shown to improve sleep efficiency, nocturnal mobility, and wake after sleep onset in some cases. While sleeping tablets or hypnotics can be used for short-term relief, they should be approached with caution due to the risk of dependence and potential adverse effects on cognition and daytime functioning.

Frequently asked questions

Some drug classifications used to produce sleep include:

- Benzodiazepines

- Nonbenzodiazepines

- Quinazolinones

- Barbiturates

- Anticonvulsants

- Antidepressants

- Anti-Parkinsonian drugs

Benzodiazepines are a class of drugs that act on GABA neuroreceptors and are commonly used to treat insomnia in the short term. They improve sleep by reducing the time it takes to fall asleep, prolonging sleep time, and reducing wakefulness.

Nonbenzodiazepines are a newer class of drugs that also act on GABA receptors to promote sleep. They may have slower tolerance development than benzodiazepines and minimal next-day impairments, but more research is needed to establish their long-term effectiveness.

Sleep disorders that these drugs can be used to treat include insomnia, sleep apnea, narcolepsy, nocturnal myoclonus syndrome, and restless leg syndrome.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment